New York State Teachers Retirement System Sells 200 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

New York State Teachers Retirement System decreased its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 0.3% in the 4th quarter, Holdings Channel reports. The firm owned 75,854 shares of the company’s stock after selling 200 shares during the quarter. New York State Teachers Retirement System’s holdings in Acadia Healthcare were worth $5,898,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in the company. Durable Capital Partners LP grew its position in shares of Acadia Healthcare by 30.8% during the 4th quarter. Durable Capital Partners LP now owns 1,941,595 shares of the company’s stock worth $159,832,000 after buying an additional 457,687 shares during the period. Macquarie Group Ltd. grew its position in shares of Acadia Healthcare by 826.5% during the 1st quarter. Macquarie Group Ltd. now owns 493,486 shares of the company’s stock worth $35,654,000 after buying an additional 440,221 shares during the period. Alyeska Investment Group L.P. acquired a new stake in shares of Acadia Healthcare during the 1st quarter worth approximately $28,751,000. Envestnet Asset Management Inc. grew its position in shares of Acadia Healthcare by 336.8% during the 1st quarter. Envestnet Asset Management Inc. now owns 461,951 shares of the company’s stock worth $5,459,000 after buying an additional 356,202 shares during the period. Finally, OFI Invest Asset Management grew its position in shares of Acadia Healthcare by 290.5% during the 3rd quarter. OFI Invest Asset Management now owns 331,129 shares of the company’s stock worth $21,990,000 after buying an additional 246,322 shares during the period.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on ACHC. UBS Group raised their price objective on shares of Acadia Healthcare from $88.00 to $102.00 and gave the stock a “buy” rating in a research report on Wednesday, February 28th. Mizuho lifted their price target on shares of Acadia Healthcare from $77.00 to $84.00 and gave the company a “neutral” rating in a research report on Wednesday, March 6th. Stephens raised shares of Acadia Healthcare from an “equal weight” rating to an “overweight” rating and set a $92.00 price target for the company in a research report on Friday, January 5th. Barclays started coverage on shares of Acadia Healthcare in a research report on Wednesday, March 6th. They issued an “overweight” rating and a $100.00 price target for the company. Finally, TD Cowen lifted their price target on shares of Acadia Healthcare from $86.00 to $101.00 and gave the company an “outperform” rating in a research report on Friday, March 1st. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $91.22.

Insiders Place Their Bets

In other news, Director Wade D. Miquelon sold 2,203 shares of Acadia Healthcare stock in a transaction on Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total transaction of $188,114.17. Following the sale, the director now directly owns 46,074 shares in the company, valued at approximately $3,934,258.86. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 2.80% of the company’s stock.

Acadia Healthcare Price Performance

ACHC opened at $73.18 on Friday. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.67 and a quick ratio of 0.67. The company has a market capitalization of $6.76 billion, a price-to-earnings ratio of -292.71, a P/E/G ratio of 2.24 and a beta of 1.31. The firm’s fifty day moving average price is $80.10 and its two-hundred day moving average price is $77.50. Acadia Healthcare Company, Inc. has a 1 year low of $66.49 and a 1 year high of $87.77.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Wednesday, February 28th. The company reported $0.85 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.80 by $0.05. The firm had revenue of $742.80 million for the quarter, compared to the consensus estimate of $727.60 million. Acadia Healthcare had a negative net margin of 0.74% and a positive return on equity of 11.21%. The business’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.70 EPS. As a group, analysts anticipate that Acadia Healthcare Company, Inc. will post 3.57 earnings per share for the current fiscal year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.